We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.92B
AUM Growth
+$154M
Cap. Flow
+$62.7M
Cap. Flow %
3.27%
Top 10 Hldgs %
26.22%
Holding
151
New
15
Increased
40
Reduced
15
Closed
11

Top Buys

Rank Stock Value
1
JELD icon
JELD-WEN Holding
JELD
+$18.8M
2
LII icon
Lennox International
LII
+$14.6M
3
AVXS
AveXis, Inc. Common Stock
AVXS
+$8.18M
4
TTD icon
Trade Desk
TTD
+$8.01M
5
VRNS icon
Varonis Systems
VRNS
+$7.91M

Top Sells

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$21.1M
2
CYBR
CyberArk
CYBR
+$14M
3
ABBV icon
AbbVie
ABBV
+$10.1M
4
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$9.2M
5
XPO icon
XPO
XPO
+$7.1M

Sector Composition

Rank Sector Weight
1 Healthcare 36.8%
2 Consumer Discretionary 13.92%
3 Technology 13.08%
4 Industrials 10.12%
5 Utilities 4.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEP icon
101
Brookfield Renewable
BEP
$9.9B
$2.72M 0.14%
145,992
+52,167
+56% +$942K
INCY icon
102
Incyte
INCY
$24.9B
$2.56M 0.13%
27,000
-13,000
-33% -$1.36M
SEP
103
DELISTED
Spectra Engy Parters Lp
SEP
$2.47M 0.13%
62,500
+12,500
+25% +$526K
ACHN
104
DELISTED
Achillion Pharmaceuticals
ACHN
$2.45M 0.13%
850,000
– –
TSRO
105
DELISTED
TESARO, Inc.
TSRO
$2.15M 0.11%
26,000
– –
FHB icon
106
First Hawaiian
FHB
$3.4B
$2.13M 0.11%
73,100
+20,600
+39% +$603K
NGNE icon
107
Neurogene
NGNE
$670M
$2.06M 0.11%
8,750
– –
ABB
108
DELISTED
ABB Ltd
ABB
$2.02M 0.11%
75,300
-4,700
-6% -$121K
JCI icon
109
Johnson Controls International
JCI
$87.8B
$2M 0.1%
52,500
+6,500
+14% +$254K
GTT
110
DELISTED
GTT Communications, Inc.
GTT
$1.98M 0.1%
+42,246
New +$1.61M
PBYI icon
111
Puma Biotechnology
PBYI
$402M
$1.98M 0.1%
20,000
– –
HMC icon
112
Honda
HMC
$39.9B
$1.85M 0.1%
54,350
+2,350
+5% +$76K
EIGR
113
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.74M 0.09%
+4,167
New +$1.49M
TSM icon
114
TSMC
TSM
$2.09T
$1.53M 0.08%
38,500
+3,500
+10% +$142K
BDN
115
Brandywine Realty Trust
BDN
$525M
$1.48M 0.08%
81,500
+2,500
+3% +$44.3K
PAYC icon
116
Paycom
PAYC
$7.53B
$1.48M 0.08%
18,382
– –
SYRS
117
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.46M 0.08%
15,000
– –
BCRX icon
118
BioCryst Pharmaceuticals
BCRX
$2.35B
$1.42M 0.07%
290,000
– –
MLKN icon
119
MillerKnoll
MLKN
$1.53B
$1.27M 0.07%
+31,700
New +$1.11M
TERP
120
DELISTED
TerraForm Power, Inc
TERP
$1.24M 0.06%
103,300
+50,800
+97% +$634K
BG icon
121
Bunge Global
BG
$20.4B
$1.23M 0.06%
18,300
+4,800
+36% +$326K
CDTX
122
DELISTED
Cidara Therapeutics
CDTX
$1.17M 0.06%
8,600
-4,600
-35% -$698K
APU
123
DELISTED
AmeriGas Partners, L.P.
APU
$1.16M 0.06%
25,000
+500
+2% +$22.5K
CMTA
124
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$1.14M 0.06%
60,000
– –
PTCT icon
125
PTC Therapeutics
PTCT
$6.26B
$1.14M 0.06%
68,200
– –
2 3 4
5
6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Eventide Asset Management held 151 positions worth $1.92B, up 8.7% from $1.76B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $62.7M of net new capital in Q4 2017, opening 15 new positions and adding to 40 existing holdings. Its largest new stake was JELD-WEN Holding: 506,500 shares worth $19.9M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was bluebird bio, an estimated $21.1M trimmed.

  • Eventide Asset Management's largest Q4 2017 buy was JELD-WEN Holding: 506,500 shares worth $19.9M.
  • Eventide Asset Management added most to AveXis, Inc. Common Stock in Q4 2017, an estimated $8.18M increase.
  • Eventide Asset Management's biggest Q4 2017 reduction was bluebird bio, cutting an estimated $21.1M.
  • Eventide Asset Management fully exited CyberArk in Q4 2017, selling an estimated $14M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $1.92B portfolio in Q4 2017.
  • Eventide Asset Management opened 15 new positions and closed 11 in Q4 2017.
  • Eventide Asset Management's portfolio value rose 8.7% quarter-over-quarter to $1.92B.

Based on Eventide Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.